Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-10-06 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −19,602 $40.24 $789K 250,445
2022-10-06 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −4,901 $40.24 $197K 191,337
2022-10-06 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Option (Right to Buy) −19,602 1,494,513
2022-10-06 Schlanger David J Executive Chairman Exercise or conversion +56,852 $0.91 $52K 139,400
2022-10-06 Schlanger David J Executive Chairman Sale −56,852 $40.26 $2.3M 82,548
2022-10-06 Schlanger David J Executive Chairman Exercise or conversion · Option (Right to Buy) −56,852 1,422,878
2022-10-05 Anevski Peter CHIEF EXECUTIVE OFFICER Gift −74,471 250,445
2022-10-05 Anevski Peter CHIEF EXECUTIVE OFFICER Gift +74,471 196,598
2022-10-05 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion +1,440 $3.95 $6K 251,885
2022-10-05 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −1,440 $40.18 $58K 250,445
2022-10-05 Anevski Peter CHIEF EXECUTIVE OFFICER Sale −360 $40.18 $14K 196,238
2022-10-05 Anevski Peter CHIEF EXECUTIVE OFFICER Exercise or conversion · Option (Right to Buy) −1,440 1,514,115
2022-10-05 Schlanger David J Executive Chairman Exercise or conversion +3,950 $0.91 $4K 86,498
2022-10-05 Schlanger David J Executive Chairman Sale −3,950 $40.18 $159K 82,548
2022-10-05 Schlanger David J Executive Chairman Exercise or conversion · Option (Right to Buy) −3,950 1,479,730
2022-09-29 Payson Norman Director Sale −6,092 $38.09 $232K 352,376
2022-09-29 Payson Norman Director Sale −526 $38.64 $20K 351,850
2022-09-28 Payson Norman Director Sale −1,900 $38.54 $73K 363,186
2022-09-28 Payson Norman Director Sale −4,718 $39.07 $184K 358,468
2022-09-15 Payson Norman Director Sale −5,718 $42.41 $243K 365,986

Page 42 of 77 · 1,524 trades